The Buzz Surrounding TruTrace Technologies Inc. (OTC: BKKSF) (TSX-V: TTT)

TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry.

About TruTrace Technologies Inc

TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis.

TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated and permanent account for cannabis strains from ownership to market.

Our Buzz on the Street videos covering TruTrace Technologies Inc. (OTC: BKKSF) (TSX-V: TTT) latest corporate News

Investor Recap

TruTrace Technologies Inc.
TTT.V $0.23 -0.0050 / -2.17%
Range 0.23 – 0.26 | 52 week range 0.22 – 0.31 | Volume $249.05K | Market cap $18.05M

The StrainSecure™ platform

Strainsecure™ protects the supply chain from illicit players. The platform uses big data with an immutable, cryptographically secure blockchain to establish a provenance for cannabis strains and their ownership.

The Main Features of Strainsecure™

CRYPTOGRAPHY

Each transaction in the supply chain is authenticated and properly identified

IMMUTABILITY

Establishes unchanged Integrity of products to
build trust

SMART CONTRACTS

Automatic execution of contracts lead to rapid transactions at a global scale

SHARED LEDGER

All participants see a uniform view of data, updated in
real-time

Strainsecure Offers Multiple Registration Types

StrainSecure’s Certification & Verification

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “StrainSecure Address” and traceable  QR Code.

Producers, patients and consumers can not only verify the test, they can also rate the product, and share reviews. This detail is stored within StrainSecure. As with the test results, these details cannot be modified or tampered with.

The Strainsecure Open Api

Blockchain open technology makes the platform available to everyone, resulting in widespread adoption and use.

StrainSecure’s secure API network fuels technology and innovation by enabling providers and software developers to build cannabis-centric applications.

StrainSecure will have billions of data points on every step of the cannabis logistics chain allowing us to own the market.

“We use big data with an immutable, cryptographically secure blockchain to establish a provenance for cannabis strains and their ownership”

May 16, 2019 - TruTrace Technologies and California-based Nonnie's Nectar Execute Letter of Intent to Begin Product Validation Program

TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company”), creator of the first blockchain-enabled fully-integrated IP tracking platform for the cannabis industry, today announced it has entered into a letter of intent dated May 15, 2019 with Nonnie’s Nectar, LLC, a Los Angeles-based hemp extract company that produces premium full-spectrum hemp-based products grown in the U.S.A. using organic farming practices, to employ the StrainSecure™ platform to collect, register, manage, track and publish verified testing data of several of their products in the market.

Under this arrangement TruTrace will produce a unique quick-response (QR) code for each associated SKU, which will then render real-time test results of each product on StrainSecure’s hosted solution. Customers will be given dynamic information on the products they are holding in their hands while still in the store. Upon completion of the collection and registration of the products, Nonnie’s Nectar will then be able to guarantee the contents, origin and quality of their products. The LOI will be superseded by a formal agreement and the transactions contemplated therein are subject to the approval of the TSX Venture Exchange.

“Our step forward with Nonnie’s Nectar is an illustration of the growing traction that our proprietary software is gaining, and the value of secure and verified testing data for this growing industry. Companies throughout the hemp and cannabis industries are recognizing the inherent and significant value in protecting and publishing the quality of their crafted products,” said TruTrace Technologies Chief Executive Officer and Director, Robert Galarza. “With our unique technology, Nonnie’s Nectar will soon be able to guarantee the safety and potency of their full-spectrum hemp extract products and support their mission of creating the highest quality extracts with no solvents, heavy metals or pesticides.”

“TruTrace Technologies will enable us to guarantee that our products contents, purity and potency are exactly as labelled, providing our customers with level assuredness about our dedication to quality control,” said Ryan Beers, Chief Executive Officer of Nonnie’s Nectar.

See full news release here: https://www.newswire.ca/news-releases/trutrace-technologies-and-california-based-nonnie-s-nectar-execute-letter-of-intent-to-begin-product-validation-program-872615649.html

May 9, 2019 - TruTrace Technologies and Canadian laboratory services company Molecular Science Corp enter into Strategic Working Relationship

TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company”) today announced that it has entered into a letter of intent dated April 30, 2019 (the “LOI”) with Molecular Science Corp. (“MSC”). Under the terms of the LOI, the parties will work together to explore opportunities to combine the blockchain-secured technology of TruTrace with the analytical expertise of MSC in order to deliver greater transparency and visibility around the quality of products being offered in the legal cannabis industry.

“Working with MSC marks a significant step forward for TruTrace in our mission to create a true testing benchmark for the Canadian cannabis market. Its comprehensive process of analytical testing on cannabis and cannabis products, including potency, terpene profiling, pesticide levels, heavy metals content and mycotoxins testing, combined with its commitment to bringing awareness to testing standards, ensures a higher level of quality control for the industry. By combining its services with the StrainSecure™ platform, we anticipate being able to finally create a benchmark for the cannabis industry,” said TruTrace CEO, Robert Galarza.

“MSC’s collaboration with TruTrace represents an important step towards establishing and maintaining world-leading standardization and transparency for cannabis quality control in this rapidly-evolving market. The integration of MSC’s analytical testing expertise with TruTrace’s robust and secure technology platform is an opportunity for both parties to make a significant contribution to this important goal,” said MSC CEO, Christian Carswell.

Terms of the LOI:

Under the terms of the LOI, the parties have agreed that: (a) TruTrace will include MSC. as a preferred partner; and (b) the parties will explore development and integration opportunities to utilize their mutual technologies to bring greater transparency and visibility to the legal cannabis industry. The parties have agreed to negotiate, settle and execute a definitive agreement formalizing their relationship (the “Formal Agreement”) on or before June 30, 2019. Entry into the Formal Agreement, and the closing of the transactions contemplated in it, are subject to certain conditions, including completion of each party’s satisfactory due diligence review of the other.

See full news release here: https://www.newswire.ca/news-releases/trutrace-technologies-and-canadian-laboratory-services-company-molecular-science-corp-enter-into-strategic-working-relationship-870425186.html

May 7, 2019 - TruTrace Technologies enters into Strategic Working Relationship with Strainprint Technologies

TruTrace Technologies Inc. (TSXV: TTT; OTC: BKKSF) (“TruTrace” or the “Company”) today announced that it has entered into a letter of intent dated April 30, 2019 (the “LOI”) with Strainprint™ Technologies Ltd. (“Strainprint”). Under the terms of the LOI, the parties will work together to explore development and integration opportunities to utilize their mutual technologies in order to bring greater transparency and visibility to the legal cannabis industry.

“We’re thrilled to begin working with Strainprint in a greater capacity. What they’ve architected from an education and data standpoint is nothing short of remarkable, and we collectively believe that a synergistic relationship between our software platforms will bring a new level of verification and trust to the efficacy of medical cannabis,” said TruTrace CEO, Robert Galarza. “We look forward to formalizing the details of our working relationship and continuing to update the industry and shareholders as our work continues to evolve.”

“We’re excited to explore combining our award-winning data, analytics and research capabilities with TruTrace’s established and powerful platform. As the leading source of medical cannabis use data, with over 60 million data points from 1.2 million medical cannabis patient reported outcomes, we are uniquely positioned to work alongside TruTrace to help drive standardization, transparency and compliance that will shape the global cannabis industry in a meaningful way,” said Strainprint CEO, Andrew Muroff.

Terms of the LOI:

Under the terms of the LOI, the parties have agreed that: (a) TruTrace will include Strainprint as a preferred partner; and (b) the parties will explore development and integration opportunities to utilize their mutual technologies to bring greater transparency and viability to the legal cannabis industry. The parties have agreed to negotiate, settle and execute a definitive agreement formalizing their relationship (the “Formal Agreement”) on or before June 30, 2019. Entry into the Formal Agreement, and the closing of the transactions contemplated in it, are subject to certain conditions, including completion of each party’s satisfactory due diligence review of the other.

See full news release here: https://www.newswire.ca/news-releases/trutrace-technologies-enters-into-strategic-working-relationship-with-strainprint-technologies-835832632.html

April 24, 2019 - Blockstrain Announces Name Change to TruTrace Technologies

Blockstrain Technology Corp. announces that, further to its News Release dated April 15, 2019, the TSX Venture Exchange has approved the change of name (“Name Change”) of the Company to TruTrace Technologies Inc. The Name Change will become effective at the opening of the market on April 24, 2019 and the company will trade under the new symbol “TTT” on the TSX Venture Exchange.

“We’re excited to continue the strong work we started under this new banner TruTrace Technologies. It is a more accurate reflection of our expanded full service enterprise software solution and better captures the full breadth of our offerings,” said Chief Executive Officer Robert Galarza. “It also better communicates the true extent of the opportunities for our technology that provides value and integrity, not just to the cannabis industry but other industries as well.”

See full news release here: https://www.newswire.ca/news-releases/blockstrain-announces-name-change-to-trutrace-technologies-891984227.html

April 15, 2019 - BLOCKStrain Announces Proposed Name Change to TruTrace Technologies Inc.

Blockstrain Technology Corp. announces that, subject to TSX Venture Exchange approval, it will change its name to TruTrace Technologies Inc.

“Evolving from BLOCKStrain to TruTrace Technologies is a reflection of our maturity as a company,” said CEO Robert Galarza. “We have developed an end-to-end enterprise software solution and wanted our branding to capture the full breadth of who we are and what we do.”

“We strongly believe in the value that blockchain provides in areas of security, transparency and intellectual property protection, and it still serves as a core feature of our platform,” says Galarza. “As we continue expanding our cannabis-focused functionality and exploring opportunities in other industries, we can do so with the confidence of a brand name that better communicates what makes us different.”

Over the coming months, the Company’s core platform BLOCKStrain™ will also be transitioning into StrainSecure™ to better showcase the level of security and transparency the Company’s technology provides producers, regulators and consumers.

See full news release here: https://www.newswire.ca/news-releases/blockstrain-announces-proposed-name-change-to-trutrace-technologies-inc–825845433.html

April 11, 2019 - BLOCKStrain Technology Appoints Dr. Gina Conte as Director of Genetics

BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced it has appointed award-winning geneticist Dr. Gina Conte to the role of Director of Genetics. Dr. Conte brings an extensive amount of expertise to her role, and will provide leadership and direction in business development.

“Dr. Conte brings significant experience and insight to BLOCKStrain, and will provide tremendous strength to our growing cadre of cannabis-based science experts,” said CEO, Robert Galarza. “Her past research into this field has provided forward momentum and knowledge around the genetics and profiling of cannabis strains, and we are excited to have her as a key part of our team as we work diligently to provide both industry participants and consumers with best-in-class technology solutions.”

“BLOCKStrain’s mission to increase transparency and integrity in the cannabis industry aligns strongly with my ongoing interest and specialization in the genetics of cannabis strains,” said Dr. Conte. “I look forward to working closely with BLOCKStrain as they continue to innovate with this industry-best technology platform.”

Dr. Conte is currently the Chief Scientific Officer at Lighthouse Genomics Inc. where she leads the company in the development and implementation of genomic services for the certification and verification of cannabis strains. Dr. Conte is also Co-founder and Chief Scientific Officer of Illuminate Data Science Inc. where she leads a research program to model the effects of cannabis strains and products on the therapeutic efficacy and experience using innovative machine learning.

In connection with this appointment BLOCKStrain has agreed to grant Dr. Conte stock options to acquire up to 250,000 common shares in the capital of BLOCKStrain, subject to the terms of a stock option agreement to be entered into by the parties.

 See full news release here:  https://www.newswire.ca/news-releases/blockstrain-technology-appoints-dr-gina-conte-as-director-of-genetics-806820487.html

April 4, 2019 - BLOCKStrain Technology to Present Keynote at MaRS HealthKick Focus Conference

BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, announced its participation at the upcoming MaRS HealthKick Focus Conference in Toronto on April 4, 2019, where Chief Executive Officer Robert Galarza will present a keynote address. 

Mr. Galarza will discuss the role that technology has played in health and wellness and more specifically, the importance of data driven ecosystem to limit disparity and bring cannabis out of the shadows and into the light of modern medicine. He will discuss the challenges that come with bridging a once illicit industry with sophisticated organizations, as well as the unique opportunities that are unfolding for innovators and entrepreneurs to support this evolving industry. From artificial intelligence and augmented reality, to decentralized ledger solutions, Mr. Galarza will discuss the exciting role that data and technology can have in helping the cannabis industry grow in Canada and beyond.

“I’m honoured for the opportunity to address participants – industry leaders and experts in the science, technology and business of cannabis – at the MaRS HealthKick Focus conference,” said Mr Galarza. “BLOCKStrain has been focused on increasing integrity and transparency in the cannabis industry and strongly believe that technological and scientific advances will enable this. We anticipate that our software can play a pivotal role as the industry continues to evolve and move forward.”

The MaRS HealthKick Focus Conference is a gathering of keynotes, panels and lightning talks from industry leaders and experts as they explore what the industry is doing to make new applications a reality.

 See full news release here: https://www.newswire.ca/news-releases/blockstrain-technology-to-present-keynote-at-mars-healthkick-focus-conference-873062751.html

April 2, 2019 - BLOCKStrain Technology Nominated for Best Software at O'Cannabiz Awards Gala

BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, announced its software suite has been nominated for “Best Software” at the O’Cannabiz Industry Awards Gala on Thursday, April 25th 2019.

“BLOCKStrain’s mission is to provide Licensed Producers, craft growers, cannabis-product developers and of course, consumers, with a high level of confidence in the quality and contents of their cannabis-based products.” said Chief Executive Officer, Robert Galarza. “We take pride in having developed what we believe is a comprehensive, best-in-class platform and are honoured to be included as a nominee in the category of ‘Best Software’ at this premier event, presented by one of Canada’s most highly-regarded business-to-business cannabis conferences.”

The Gala, which will be held during the O’Cannabiz conference, taking place from April 25 to 27, 2019 in Toronto, is a celebration and exclusive event to recognize the industry’s best professionals and products in 35 categories. Registered voters will only be able to vote once, per email address, during the voting period, which closes at 12:00 p.m. Eastern time (9:00 a.m. Pacific time) on April 3, 2019. Once registered, voter information will be stored in the O’Cannabiz database so users may come back and complete their voting at their leisure (until voting closes on April 03, 2019).

All winners will be announced live at the The O’Cannabiz Industry Awards Gala.

 

See full news release here: https://www.newswire.ca/news-releases/blockstrain-technology-nominated-for-best-software-at-o-cannabiz-awards-gala-812330049.html

8 Comments
  1. Ellio Hernandez 2 weeks ago
    Reply

    Using secured data encryption in the cannabis industry can aid in moving the industry forward

    • Helen Quach 2 weeks ago
      Reply

      What if the government imposes strict regulations on blockchain?

      • Ian Tom 2 weeks ago
        Reply

        Having a network where only cannabis-related investors and industry influencers in one secured forum would be a game-changing platform while retaining anonymity of course. That would work as long as government regulations hold.

  2. Nicholas Santiago 1 week ago
    Reply

    Securing your intellectual property (IP) – including everything from patents, trademarks, copyrights, industrial designs and trade secrets is imperative. #free #innovation

    • Courtney P. 5 days ago
      Reply

      the scary thing about going fully digital is cyber attacks, how can we ensure that this is safe moving towards the future?

      • Viktor Ferrera 4 days ago
        Reply

        it is inevitable, the demand for cyber security will continue to rise as our dependence on technology increases

  3. Luke Noles 6 days ago
    Reply

    Who knew Blockchain technology could be utilized in this way, having a secured and trusted database for cannabis and an integrated review system is like an all in one Yelp

    • Harold Wesley 6 days ago
      Reply

      Blockchain in cannabis: two industries that I’d never thought would co-exist but here we are.

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For trutrace technologies inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated twenty five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.